- Home
- RGLS vs NMT Comparison
RGLS vs NMT Comparison
Compare RGLS & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- NMT
- Stock Information
- Founded
- RGLS 2007
- NMT 1993
- Country
- RGLS United States
- NMT United States
- Employees
- RGLS N/A
- NMT N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- NMT Finance/Investors Services
- Sector
- RGLS Health Care
- NMT Finance
- Exchange
- RGLS Nasdaq
- NMT Nasdaq
- Market Cap
- RGLS 102.1M
- NMT 108.6M
- IPO Year
- RGLS 2012
- NMT N/A
- Fundamental
- Price
- RGLS $1.42
- NMT $11.71
- Analyst Decision
- RGLS Strong Buy
- NMT
- Analyst Count
- RGLS 6
- NMT 0
- Target Price
- RGLS $10.33
- NMT N/A
- AVG Volume (30 Days)
- RGLS 493.3K
- NMT 19.1K
- Earning Date
- RGLS 11-07-2024
- NMT 01-01-0001
- Dividend Yield
- RGLS N/A
- NMT 3.21%
- EPS Growth
- RGLS N/A
- NMT N/A
- EPS
- RGLS N/A
- NMT N/A
- Revenue
- RGLS N/A
- NMT N/A
- Revenue This Year
- RGLS N/A
- NMT N/A
- Revenue Next Year
- RGLS N/A
- NMT N/A
- P/E Ratio
- RGLS N/A
- NMT N/A
- Revenue Growth
- RGLS N/A
- NMT N/A
- 52 Week Low
- RGLS $1.08
- NMT $9.05
- 52 Week High
- RGLS $3.79
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- RGLS 41.95
- NMT 48.24
- Support Level
- RGLS $1.36
- NMT $11.62
- Resistance Level
- RGLS $1.65
- NMT $11.80
- Average True Range (ATR)
- RGLS 0.10
- NMT 0.16
- MACD
- RGLS -0.01
- NMT -0.02
- Stochastic Oscillator
- RGLS 28.57
- NMT 12.70
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified, closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.